Related Experiment Video
Updated: Jul 18, 2026

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
Quinolones inhibit DNA religation mediated by Staphylococcus aureus topoisomerase IV. Changes in drug mechanism
V E Anderson1, R P Zaniewski, F S Kaczmarek
1Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA.
Abstract:
Quinolones are the most active oral antibacterials in clinical use and act by increasing DNA cleavage mediated by prokaryotic type II topoisomerases. Although topoisomerase IV appears to be the primary cytotoxic target for most quinolones in Gram-positive bacteria, interactions between the enzyme and these drugs are poorly understood. Therefore, the effects of ciprofloxacin on the DNA cleavage and religation reactions of Staphylococcus aureus topoisomerase IV were characterized. Ciprofloxacin doubled DNA scission at 150 nM drug and increased cleavage approximately 9-fold at 5 microM. Furthermore, it dramatically inhibited rates of DNA religation mediated by S. aureus topoisomerase IV. This inhibition of religation is in marked contrast to the effects of antineoplastic quinolones on eukaryotic topoisomerase II, and suggests that the mechanistic basis for quinolone action against type II topoisomerases has not been maintained across evolutionary boundaries. The apparent change in quinolone mechanism was not caused by an overt difference in the drug interaction domain on topoisomerase IV. Therefore, we propose that the mechanistic basis for quinolone action is regulated by subtle changes in drug orientation within the enzyme.drug.DNA ternary complex rather than gross differences in the site of drug binding.
Insights
Ciprofloxacin enhances DNA cleavage by Staphylococcus aureus topoisomerase IV, significantly inhibiting DNA religation. This suggests subtle drug-enzyme interactions, not binding site differences, explain quinolone mechanism variations across species.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Quinolones are potent oral antibacterials targeting prokaryotic type II topoisomerases.
- Topoisomerase IV is a key target for quinolones in Gram-positive bacteria, but drug interactions are not fully understood.
Purpose of the Study:
- To investigate the effects of ciprofloxacin on DNA cleavage and religation by Staphylococcus aureus topoisomerase IV.
Main Methods:
- Characterization of DNA cleavage and religation reactions mediated by purified S. aureus topoisomerase IV in the presence of varying ciprofloxacin concentrations.
Main Results:
- Ciprofloxacin significantly increased DNA scission by S. aureus topoisomerase IV in a dose-dependent manner.
- Ciprofloxacin dramatically inhibited the DNA religation activity of S. aureus topoisomerase IV.
Conclusions:
- The mechanism of quinolone action may differ between bacterial and eukaryotic type II topoisomerases, with religation inhibition being a key factor in bacteria.
- Subtle alterations in drug orientation within the enzyme-drug-DNA complex, rather than changes in the binding site, likely explain these mechanistic differences.
More Related Videos
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis

